June 9-16, 2016
Last Updated: Jun 11, 2016
- Chemokine genetic polymorphism in human health and disease.
Qidwai Tabish, et al. Immunology letters 2016 6 - Commentary regarding Schayek et al., entitled "The rate of recurrent BRCA1, BRCA2, and TP53 mutations in the general population, and unselected ovarian cancer cases, in Belo Horizonte, Brazil".
Sales Luiz Vianna Fernanda, et al. Cancer genetics 2016 4 - Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.
Teerlink Craig C, et al. Human genetics 2016 6 - Enhanced Risk-Based Lung Cancer Screening May Prevent More Deaths than Current Approaches
NCI, June 2016 - State of the science on prevention and screening to reduce melanoma incidence and mortality: The time is now.
Tripp Mary K et al. CA: a cancer journal for clinicians 2016 May - BRAF V600E mutation in metastatic colorectal cancer: methods of detection and correlation with clinical and pathologic features.
Roma Cristin, et al. Cancer biology & therapy 2016 6 0 - Copy number analysis of whole-genome data using BIC-seq2 and its application to detection of cancer susceptibility variants.
Xi Ruibin, et al. Nucleic acids research 2016 6 - Distribution of EGFR Mutations in 10,607 Russian Patients with Lung Cancer.
Imyanitov Evgeny N, et al. Molecular diagnosis & therapy 2016 6 - Intercalated chemotherapy and erlotinib for non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutations.
Zwitter Matjaz, et al. Cancer biology & therapy 2016 6 0 - Risk of second primary cancers after malignant mesothelioma and vice versa.
Chen Tianhui, et al. Cancer letters 2016 5 (1) 94-99 - rs11895168 C allele and the increased risk of breast cancer in Isfahan population.
Salimi Zohreh, et al. Breast (Edinburgh, Scotland) 2016 6 89-94 - Shorter EGFR Dinucleotide Repeat Length Predicts Better Response of Patients with Advanced Non-small Cell Lung Cancer to EGFR Tyrosine Kinase Inhibitor.
Chen Bin, et al. Cell biochemistry and biophysics 2015 12 (3) 799-804 - Something Old, Something New, Something Borrowed, Something Fused: Novel EGFR Rearrangements in Lung Adenocarcinomas.
Paik Paul K, et al. Cancer discovery 2016 6 (6) 574-5 - The coexistence of MET over-expression and an EGFR T790M mutation is related to acquired resistance to EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer.
Gou Lan-Ying, et al. Oncotarget 2016 5 - ‘Liquid biopsy’ study offers hope for a blood test to find cancer
L McGinley, Washington Post, June 4, 2016 - Application of advanced molecular technology in the diagnosis and management of genetic disorders in South Africa.
Kotze M et al. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2016 106(6) 11012 - Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine.
Green Robert C et al. American journal of human genetics 2016 Jun 98(6) 1051-66 - Clinical Validation of Targeted Next Generation Sequencing for Colon and Lung Cancers.
D'Haene Nicky et al. PloS one 2015 10(9) e0138245 - Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization.
Ali Siraj M et al. The oncologist 2016 May - Considerations for Implementation of Cancer Molecular Diagnostics Into Clinical Care.
Hayes Daniel F et al. American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting 2016 35292-6 - Cytogenetics and Molecular Genetics of Prostate Cancer: A Comprehensive Update.
Fonseka Laksha N et al. Journal of the Association of Genetic Technologists 2015 41(3) 100-11 - Exclusive: Breast cancer gene database gives clearer picture of risk,
by Susan Miller, USA Today, June 1, 2016 - Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy.
Ellingson Marissa S et al. Breast cancer research and treatment 2015 Sep 153(2) 435-43 - FDA approves first blood test to detect gene mutation associated with non-small cell lung cancer,
FDA, June 1, 2016 - Frequently Asked Questions About Genetic Testing and Cancer,
by Joy Larsen Haidle, National Society of Genetic Counselors, June 3, 2016 - Genetic testing for the risk of developing late effects among survivors of childhood cancer: Consumer understanding, acceptance, and willingness to pay.
Georgiou Gabrielle et al. Cancer 2016 Jun - How do women trade-off benefits and risks in chemotherapy treatment decisions based on gene expression profiling for early-stage breast cancer? A discrete choice experiment.
Marshall Deborah A et al. BMJ open 2016 6(6) e010981 - How Far Do We Go With Genetic Evaluation? Gene, Panel, and Tumor Testing.
Lynce Filipa et al. American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting 2016 35e72-8 - Implications of using whole genome sequencing to test unselected populations for high risk breast cancer genes: a modelling study.
Warren-Gash Charlotte et al. Hereditary cancer in clinical practice 2016 1412 - Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database.
Møller Pål et al. Gut 2016 Jun
- Human (0)
- Pathogen (37)
- Human (29834)
- Pathogen (0)
.png)
No hay comentarios:
Publicar un comentario